UNSPSC 85731846: Replacement of urethra with autologous tissue substitute, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of urethra with autologous tissue substitute, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0TRD47Z

UNSPSC 85731846 Replacement of urethra with autologous tissue substitute, percutaneous endoscopic approach is a Commodity code that shows little relevant recent activity in state and local procurement. The code nominally describes a specific surgical procedure, yet recent opportunities posted under this code span independent medical evaluation services, surgical benefit carve-outs, occupational medical surveillance, emergency and specialty medical care for detained youth, pharmacy benefit management, and temporary health professional staffing — none of which align with urological reconstruction surgery or autologous tissue grafting. The mismatch suggests that either the code has been applied inconsistently by issuing bodies or the opportunities in the dataset were tagged incorrectly. State and local purchasing offices appear not to be procuring urethral reconstruction services as a line item; rather, they are contracting for medical administration, staffing, and benefits management services across multiple clinical domains.

The recent opportunities originate from diverse issuing bodies: a city retirement board (Phoenix), a municipal benefits department (Long Beach), a state transportation agency (Washington), a county juvenile probation department (Harris County, Texas), a county board of commissioners (Collier County, Florida), and a regional public health system (Santa Clara County, California). The geographic spread includes Arizona, California, Florida, Texas, and Washington. Because the code's nominal scope does not match the work actually being solicited, this code does not present a decision signal for firms pursuing state and local medical device, surgical supply, or tissue-substitute procurement opportunities.